Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer

DeepDyve requires Javascript to function. Please enable Javascript on your browser to continue.

Zhang, J.; Lin, Y.; Sun, X.J.; Wang, B.Y.; Wang, Z.H.;

Annals of Oncology – Aug 1, 2018

Download PDF

Zhang, J.; Lin, Y.; Sun, X.J.; Wang, B.Y.; Wang, Z.H.;

Annals of Oncology – Aug 1, 2018

Loading next page...

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.